The Role of Analgesics and Intra-Articular Injections in Disease Management

Medical Clinics of North America

Volumn 93, Issue 1, 2009, Pages 201-211

  Harvey, William F ^a   Hunter, David J ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

Analgesics; Hyaluronic acid; Intra articular; NSAIDS; Osteoarthritis; Pharmacology

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANALGESIC AGENT; ASCORBIC ACID; BETA CAROTENE; CAPSAICIN; CELECOXIB; CHONDROITIN; CORTICOSTEROID; DICLOFENAC; DICLOFENAC DIETHYLAMINE; DIETHYLAMINE; FAMOTIDINE; GLUCOSAMINE; HYALURONIC ACID; INDOMETACIN; LIDOCAINE; METHYLPREDNISOLONE; MISOPROSTOL; MONOAMINE OXIDASE INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR; SALICYLIC ACID; SALICYLIC ACID METHYL ESTER; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRIAMCINOLONE; VITAMIN K GROUP;

BURNING SENSATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DROWSINESS; FLUSHING; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GEL; HUMAN; KIDNEY DISEASE; LOCAL SKIN REACTION; META ANALYSIS; NAUSEA; NEPHROTOXICITY; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; REVIEW; SEROTONIN SYNDROME; SIDE EFFECT; SKIN IRRITATION; STOMACH ULCER; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; CHONDROITIN; DIETARY SUPPLEMENTS; GLUCOSAMINE; HUMANS; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; VISCOSUPPLEMENTS;

EID: 57049109385     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2008.07.010     Document Type: Review

References (68)

1. Center for Disease Control. Arthritis prevalence and activity limitations-United States, 1990-1990. MMWR Morb Mortal Wkly Rep 43 24 (1994) 433-438
2. Badley E., and DesMeules M. Arthritis in Canada an ongoing challenge (2003), Health Canada, Ottawa (Ontario)
3. Martin J.A., and Buckwalter J.A. Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis. Iowa Orthop J 21 (2001) 1-7
4. Felson D.T. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 42 1 (2004) 1-9 v
5. Hochberg M.C., Altman R.D., Brandt K.D., et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee: American College of Rheumatology. Arthritis Rheum 38 11 (1995) 1541-1546
6. Clissold S.P. Paracetamol and phenacetin. Drugs 32 Suppl 4 (1986) 46-59
7. Graham G.G., Scott K.F., and Day R.O. Tolerability of paracetamol. Drug Saf 28 3 (2005) 227-240
8. Shen H., Sprott H., Aeschlimann A., et al. Analgesic action of acetaminophen in symptomatic osteoarthritis of the knee. Rheumatology (Oxford) 45 6 (2006) 765-770
9. Altman R.D., Zinsenheim J.R., Temple A.R., et al. Three-month efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage 15 4 (2007) 454-461
10. Hill C.L., Hunter D.J., Niu J., et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 66 12 (2007) 1599-1603
11. Hunter D.J., Zhang Y., Niu J., et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 54 5 (2006) 1529-1535
12. Garcia Rodriguez L.A., Hernandez-Diaz S., Garcia Rodriguez L.A., et al. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. [see comment]. Epidemiology 12 5 (2001) 570-576
13. Rahme E., Pettitt D., LeLorier J., et al. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal anti-inflammatory drugs in an elderly population. [see comment]. Arthritis Rheum 46 11 (2002) 3046-3054
14. Dayer P., Collart L., and Desmeules J. The pharmacology of tramadol. Drugs 47 Suppl 1 (1994) 3-7
15. Cepeda M.S., Camargo F., Zea C., et al. Tramadol for osteoarthritis: a systematic review and meta-analysis. J Rheumatol 34 3 (2007) 543-555
16. Kalso E., Edwards J.E., Moore R.A., et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112 3 (2004) 372-380
17. Markenson J.A., Croft J., Zhang P.G., et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 21 6 (2005) 524-535
18. Weaver M., and Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 18 4 Suppl (2002) S61-S69
19. Tannenbaum H., Davis P., Russell A.S., et al. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. CMAJ 155 1 (1996) 77-88
20. Todd P.A., Clissold S.P., and Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs 40 1 (1990) 91-137
21. Blin O., Pailhous J., Lafforgue P., et al. Quantitative analysis of walking in patients with knee osteoarthritis: a method of assessing the effectiveness of non-steroidal anti-inflammatory treatment. Ann Rheum Dis 49 12 (1990) 990-993
22. Huskisson E.C., Berry H., Gishen P., et al. Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee: LINK Study Group. Longitudinal Investigation of Nonsteroidal Anti-inflammatory Drugs in Knee Osteoarthritis. J Rheumatol 22 10 (1995) 1941-1946
23. Flower R.J. Studies on the mechanism of action of anti-inflammatory drugs: a paper in honour of John Vane. Thromb Res 110 5-6 (2003) 259-263
24. Flower R.J. The development of COX-2 inhibitors. Nat Rev Drug Discov 2 3 (2003) 179-191
25. Lanza F.L. A guideline for the treatment and prevention of NSAID-induced ulcers: members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 93 11 (1998) 2037-2046
26. Silverstein F.E., Graham D.Y., Senior J.R., et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 123 4 (1995) 241-249
27. Scheiman J.M., Yeomans N.D., Talley N.J., et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 101 4 (2006) 701-710
28. Taha A.S., Hudson N., Hawkey C.J., et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs. N Engl J Med 334 22 (1996) 1435-1439
29. Silverstein F.E., Faich G., Goldstein J.L., et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study. A randomized controlled trial: Celecoxib Long-term Arthritis Safety Study. JAMA 284 10 (2000) 1247-1255
30. Lai K.C., Chu K.M., Hui W.M., et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 4 7 (2006) 860-865
31. Huerta C., Castellsague J., Varas-Lorenzo C., et al. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 45 3 (2005) 531-539
32. Abraham P., and Keane W. Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs. Am J Nephrol 4 1 (1984) 1-6
33. Hippisley-Cox J., and Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330 (2005) 1366-1369
34. Bennett J.S., Daugherty A., Herrington D., et al. The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association. Circulation 111 13 (2005) 1713-1716
35. Niethard F.U., Gold M.S., Solomon G.S., et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol 32 12 (2005) 2384-2392
36. Lin J., Zhang W., Jones A., et al. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329 7461 (2004) 324
37. Bookman A.A., Williams K.S., Shainhouse J.Z., et al. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. [see comment]. CMAJ 171 4 (2004) 333-338
38. Altman R.D., Longley S., and Rachidi S. Topical diclofenac sodium gel for knee osteoarthritis. [abstract]. Osteoarthritis Cartilage 15 Suppl C (2007) C225
39. Mason L., Moore R.A., Edwards J.E., et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 328 7446 (2004) 995
40. Mason L., Moore R.A., Derry S., et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328 7446 (2004) 991
41. McCarthy G.M., and McCarty D.J. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 19 4 (1992) 604-607
42. Deal C.L., Schnitzer T.J., Lipstein E., et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 13 3 (1991) 383-395
43. Burch F., Codding C., Patel N., et al. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients: a prospective, multicenter, open-label effectiveness trial. Osteoarthritis Cartilage 12 3 (2004) 253-255
44. Arroll B., and Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 328 7444 (2004) 869
45. Bellamy N., Campbell J., Robinson V., et al. Intra-articular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2 (2006) CD005328
46. Raynauld J.P., Buckland-Wright C., Ward R., et al. Safety and efficacy of long-term intra-articular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 48 2 (2003) 370-377
47. Behrens F., Shepard N., Mitchell N., et al. Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J Bone Joint Surg Am 57 1 (1975) 70-76
48. Papacrhistou G., Anagnostou S., Katsorhis T., et al. The effect of intra-articular hydrocortisone injection on the articular cartilage of rabbits. Acta Orthop Scand Suppl 275 (1997) 132-134
49. Jones A., and Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 55 11 (1996) 829-832
50. Akmal M., Singh A., Anand A., et al. The effects of hyaluronic acid on articular chondrocytes. J Bone Joint Surg Br 87 8 (2005) 1143-1149
51. Waddell D.D., Kolomytkin O.V., Dunn S., et al. Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue. Clin Orthop Relat Res 465 (2007) 241-248
52. Arrich J., Piribauer F., Mad P., et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172 8 (2005) 1039-1043
53. Lo G.H., LaValley M., McAlindon T., et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290 23 (2003) 3115-3121
54. Reichenbach S., Blank S., Rutjes A.W., et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 57 8 (2007) 1410-1418
55. Juni P., Reichenbach S., Trelle S., et al. Efficacy and safety of intra-articular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 56 11 (2007) 3610-3619
56. Towheed T.E., Maxwell L., Anastassiades T.P., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2 (2005) CD002946
57. Vlad S.C., LaValley M.P., McAlindon T.E., et al. Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis Rheum 56 7 (2007) 2267-2277
58. Clegg D.O., Reda D.J., Harris C.L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. [see comment]. N Engl J Med 354 8 (2006) 795-808
59. Neogi T., Booth S.L., Zhang Y.Q., et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum 54 4 (2006) 1255-1261
60. Neogi T., Felson D.T., Sarno R., et al. Vitamin K in hand osteoarthritis: results from a randomized clinical trial. [abstract]. Osteoarthritis Cartilage 15 Suppl C (2007) C228-C229
61. Jordan J.M., Fang F., Schwartz T.A., et al. Low selenium levels are associated with increased odds of radiographic hip osteoarthritis in African American and white women. [abstract]. Osteoarthritis Cartilage 15 Suppl C (2008) C33
62. McAlindon T.E., Jacques P., Zhang Y., et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?. Arthritis Rheum 39 4 (1996) 648-656
63. McAlindon T., and Felson D.T. Nutrition: risk factors for osteoarthritis. Ann Rheum Dis 56 7 (1997) 397-400
64. Dray A., and Read S.J. Arthritis and pain: future targets to control osteoarthritis pain. Arthritis Res Ther 9 3 (2007) 212
65. Anonymous. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43 9 (2000) 1905-1915
66. Jordan K.M., Arden N.K., Doherty M., et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62 12 (2003) 1145-1155
67. Zhang W., Doherty M., Arden N., et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64 5 (2005) 669-681
68. Zhang W., Moskovitz R., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16 2 (2008) 137-162